Impaired prostacyclin synthesis by vessel walls in Behçet's disease. 1986

E Kansu, and G Sahin, and F Sahin, and B Sivri, and I Sayek, and F Batman

UI MeSH Term Description Entries
D008297 Male Males
D004727 Endothelium A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body. Endotheliums
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001528 Behcet Syndrome Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well. Behcet Disease,Behcet's Disease,Behcet's Syndrome,Triple-Symptom Complex,Adamantiades-Behcet Disease,Behcet Triple Symptom Complex,Behçet Disease,Old Silk Route Disease,Triple Symptom Complex,Adamantiades Behcet Disease,Adamantiades-Behcet Diseases,Behçet Diseases,Symptom Complex, Triple,Triple Symptom Complices
D014680 Veins The vessels carrying blood away from the CAPILLARY BEDS. Vein
D015121 6-Ketoprostaglandin F1 alpha The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue. 6-Keto-PGF1 alpha,6-Oxo-PGF1 alpha,6-Oxoprostaglandin F1 alpha,6 Ketoprostaglandin F1 alpha,6 Keto PGF1 alpha,6 Oxo PGF1 alpha,6 Oxoprostaglandin F1 alpha,F1 alpha, 6-Ketoprostaglandin,F1 alpha, 6-Oxoprostaglandin,alpha, 6-Keto-PGF1,alpha, 6-Ketoprostaglandin F1,alpha, 6-Oxo-PGF1,alpha, 6-Oxoprostaglandin F1

Related Publications

E Kansu, and G Sahin, and F Sahin, and B Sivri, and I Sayek, and F Batman
August 1985, Lancet (London, England),
E Kansu, and G Sahin, and F Sahin, and B Sivri, and I Sayek, and F Batman
September 1982, Prostaglandins,
E Kansu, and G Sahin, and F Sahin, and B Sivri, and I Sayek, and F Batman
June 2017, European heart journal. Cardiovascular Imaging,
E Kansu, and G Sahin, and F Sahin, and B Sivri, and I Sayek, and F Batman
December 2002, The American journal of pathology,
E Kansu, and G Sahin, and F Sahin, and B Sivri, and I Sayek, and F Batman
January 1996, Rheumatology international,
E Kansu, and G Sahin, and F Sahin, and B Sivri, and I Sayek, and F Batman
January 2001, Internal medicine (Tokyo, Japan),
E Kansu, and G Sahin, and F Sahin, and B Sivri, and I Sayek, and F Batman
January 2011, Current opinion in rheumatology,
E Kansu, and G Sahin, and F Sahin, and B Sivri, and I Sayek, and F Batman
January 1982, VASA. Zeitschrift fur Gefasskrankheiten,
E Kansu, and G Sahin, and F Sahin, and B Sivri, and I Sayek, and F Batman
May 2020, Stroke,
E Kansu, and G Sahin, and F Sahin, and B Sivri, and I Sayek, and F Batman
October 1996, Journal of internal medicine,
Copied contents to your clipboard!